Immunotherapy for bladder cancer
Oliver Fuge,1 Nikhil Vasdev,1 Paula Allchorne,2 James SA Green2 1Department of Urology, Lister Hospital, Stevenage, UK; 2Department of Urology, Bartshealth NHS Trust, Whipps Cross Rd, London, UK Abstract: It is nearly 40 years since Bacillus Calmette–Guérin (BCG) was first used...
Main Authors: | Fuge O, Vasdev N, Allchorne P, Green JSA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | Research and Reports in Urology |
Online Access: | http://www.dovepress.com/immunotherapy-for-bladder-cancer-peer-reviewed-article-RRU |
Similar Items
-
Role of immunotherapy in bladder cancer
by: Logan P. Rhea, et al.
Published: (2021-01-01) -
BCG in Bladder Cancer Immunotherapy
by: Song Jiang, et al.
Published: (2022-06-01) -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
by: Ashish M. Kamat, et al.
Published: (2017-08-01) -
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
by: Ashish M. Kamat, et al.
Published: (2017-09-01) -
Knowledge-map analysis of bladder cancer immunotherapy
by: Zongwei Lv, et al.
Published: (2023-12-01)